In cancer cells, TERT is transcriptionally reactivated by oncogenic transcription factors such as Myc, NF-κB, β-catenin, and SP18,11,12, and TERT expression is elevated in HCC patients and positively correlated with the incidence and development of HCC13,14. The gene discussed is TERT; the disease is hepatocellular carcinoma.